McClellan takes to the airways
Executive Summary
During a Jan. 15 appearance on National Public Radio's "Diane Rehm Show," Commissioner McClellan responded to questions about pressure from Congress to speed up approval times: "We do get pressure from Congress and other constituents...[but] I think we've got some win-win opportunities here." McClellan cited the additional resources and authorities afforded to the agency through the reauthorization of the Prescription Drug User Fee Act and noted that FDA will be expanding its staff for reviewing medical treatments and devices...
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.